Enanta Pharmaceuticals Inc (ENTA)

Other Income/Expenses (Net)

-$2.23M

Quarterly · Period ending: · USD

ENTA logo

ENTA Other Income/Expenses (Net)

Latest reported-$2.23M
ENTA Quarterly Other Income/Expenses (Net) ($142.00K → -$2.23M)
High-resolution chart · PNG

ENTA other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Enanta Pharmaceuticals Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-2,229,000
-1,232,000
-661,000
-282,000
667,000
578,000
837,000
668,000
1,132,000
1,246,000
857,000
1,513,000
1,869,000
1,837,000
993,000
714,000
393,000
255,000
258,000
333,000
439,000
545,000
677,000
1,149,000
1,445,000
1,950,000
2,076,000
2,274,000
2,415,000
2,245,000
1,885,000
1,429,000
1,338,000
1,066,000
960,000
660,000
600,000
549,000
524,000
471,000
447,000
472,000
329,000
509,000
287,000
210,000
301,000
236,000
36,000
-76,000
87,000
258,000
40,000
252,000
48,000
117,000
27,000
16,000
23,000
142,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.